Application of monoclonal antibodies in tumor pathology
著者
書誌事項
Application of monoclonal antibodies in tumor pathology
(Developments in oncology, 50)
Nijhoff , Distributors for the U.S. and Canada, Kluwer Academic Publishers, 1987
大学図書館所蔵 全12件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Based on a post-graduate Boerhaave course on "Application of monoclonal antibodies in cancer diagnosis," that was held in January 1986 in Leiden, the Netherlands"--Introd
Includes bibliographies and index
内容説明・目次
内容説明
The development of monoclonal antibodies to human tumor associated antigens has greatly facilitated the application of immunohistochemical techniques to analyze surgically removed tissues. During the last few years this approach has been utilized by a progressively increasing number of investigators to analyze malignant cells. Although monoclonal antibodies to tumor associated antigens have not become yet routine reagents in immunopathology, they have provided new information which could not be obtained with conventional antisera or histochemical procedures. The following are representative examples. TUmor associated antigens have been identified which display a restricted distribution in normal tissues and therefore may represent useful markers for radio- imaging and appropriate targets for immunotherapy. In spite of undetec- table differences with conventional histopathological approaches hetero- geneity has been found in the antigenic profile of tumor cells within a lesion, in autologous lesions removed from different anatomic sites from a given patient and in lesions removed from different patients. Phenotypes of tumor cells have been identified which correlate with the biology of tumor cells and with the clinical course of the disease. From a practical view point the use of monoclonal antibodies in immunopathology has enhanced interactions between pathologists and immunologists, as exemplified by the present book. Such interactions have contributed to the application of basic research to clinical problems. The chapter of this book discuss investigations performed with monoclonal antibodies to antigens expressed by various types of normal and malignant human cells.
目次
I. Basic and Technical Aspects..- 1. Selection of monoclonal antibodies..- 2. Immunocytochemical techniques..- 3. Double immunoenzyme staining methods with special reference to monoclonal antibodies..- II. Tumor Associated Antigens..- 4. Monoclonal antibodies to oncofetal antigens..- 5. Cytoskeletal proteins as markers in surgical pathology..- 6. Immunological marker analysis in the various hematopoietic differentiation stages and their malignant counterparts..- 7. Monoclonal antibodies in lymphoma diagnosis and classification..- 8. Monoclonal antibodies recognizing melanoma-associated antigens..- 9. Monoclonal antibodies in breast tumor pathology..- 10. Monoclonal antibodies in clinical and experimental pathology of lung cancer..- 11. Monoclonal antibodies in diagnosis and prognosis of colorectal cancer..- 12. Monoclonal antibodies reacting with tumors of the urological tract or prostate..- 13. Monoclonal antibodies against ovarian cancer..- 14. Endocrine tumors..- 15. Application of monoclonal antibodies in cytopathology..- 16. Tumor associated antigens and oncogene products defined by monoclonal antibodies..- III. Practical Application and Case Presentations..- 17. Practical application of monoclonal antibodies in diagnostic tumor pathology and some future perspectives..- 18. Case 1: Carcinoma or large-cel lymphoma? Immunohistochemical approach of undifferentiated tumors in the skin..- 19. Case 2: Carcinoma or sarcoma?.- 20. Case 3: Type of sarcoma?.- 21. Case 4: Type of smal-cell undifferentiated cancer?.- 22. Case 5: Type of epitheloid and clear cell cancer?.- 23. Case 6: Mesothelioma or adenocarcinoma?.- 24. Case 7: Origin of metastatic carcinoma?.- 25. Case 8: Type of carcinoma in the liver?.- 26. Case 9: Metastatic meningioma: a rare cause of diffuse nodular lung disease..- Appendix: 1. List of monoclonal antibodies useful in histopathology..- Appendix: 2. Suppliers/distributors..- Index of Subjects..
「Nielsen BookData」 より